Adult Dosing
Diabetes Mellitus
Novolog/Novorapid
- Individualizing regimens with an intermediate or long-acting insulin plus a rapid-acting insulin before meals is common
- 50%-70% of total insulin requirements are usually provided by rapid/ultra-short insulin, with the remaining 30%-50% provided by intermediate or long-acting insulin
- Usual total daily insulin requirements are 0.5-1 U/kg/day SC divided 2-4 times daily; give <15 min before meals
- May infuse SC by an external insulin pump. Diluted insulin should not be used in external insulin pumps. Programming insulin infusion pumps is based on the patients usual total daily insulin dose
- Onset approx 15-30 minutes (regular insulin 30-60 minutes), peak approx 1-3 hours, duration 3-5 hours for rapid-acting insulins (Novolog, Novorapid)
- Patients need to be aware that insulin dose changes should be done based upon an agreed upon protocol under medical supervision
- Notes
- Rapid Insulin (Novolog/Novorapid) may be administered IV, diluted in 0.9% sodium chloride in concentrations of 0.05-1 unit/mL
- Any change of insulin dose should be made with careful consideration of glucose levels, current dosage and patterns of high and/or low blood glucose levels
- Safety and efficacy in pediatric patients <2 yrs has not been established
- Continuous subcutaneous infusion pump
- Avoid mixing or diluting when using in an external insulin infusion pump
- Intravenous infusion
- Dilute to 0.05-1 unit/mL for IV administration in 0.9% sodium chloride in polyvinyl chloride infusion bags
- Dosing typically 0.1 U/kg/hr as an IV infusion (for DKA) [see separate topic on DKA]
- As with all IV uses of insulin; carefully monitor glycemic response and potassium levels
Pediatric Dosing
Diabetes Mellitus-Children >2 yrs
Novolog/Novorapid
- Individualizing regimens with an intermediate or long-acting insulin plus a rapid-acting insulin before meals is common
- 50%-70% of total insulin requirements are usually provided by rapid/ultra-short insulin, with the remaining 30%-50% provided by intermediate or long-acting insulin
- Usual total daily insulin requirements are 0.5-1 U/kg/day SC divided 2-4 times daily; give <15 min before meals
- May infuse SC by an external insulin pump. Diluted insulin should not be used in external insulin pumps. Programming insulin infusion pumps is based on the patients usual total daily insulin dose
- Onset approx 15-30 minutes (regular insulin 30-60 minutes), peak approx 1-3 hours, duration 3-5 hours for rapid-acting insulins (Novolog, Novorapid)
- Patients need to be aware that insulin dose changes should be done based upon an agreed upon protocol under medical supervision
- Notes
- Rapid Insulin (Novolog/Novorapid) may be administered IV, diluted in 0.9% sodium chloride in concentrations of 0.05-1 unit/mL
- Any change of insulin dose should be made with careful consideration of glucose levels, current dosage and patterns of high and/or low blood glucose levels
- Safety and efficacy in pediatric patients <2 yrs has not been established
- Continuous subcutaneous infusion pump
- Avoid mixing or diluting when using in an external insulin infusion pump
- Intravenous infusion
- Dilute to 0.05-1 unit/mL for IV administration in 0.9% sodium chloride in polyvinyl chloride infusion bags
- Dosing typically 0.1 U/kg/hr as an IV infusion (for DKA) [see separate topic on DKA]
- As with all IV uses of insulin; carefully monitor glycemic response and potassium levels
[Outline]
See Supplemental Patient Information
- This drug should immediately be followed by a meal within 5-10 minutes
- Insulin aspart has a rapid onset and short duration of action, some patients may require more basal insulin and more total insulin to prevent pre-meal hyperglycemia when using insulin aspart than when using human regular insulin
- When used in meal related use, 50-70% of the total daily insulin requirements can be provided by insulin aspart with the remainder being provided by longer acting insulin
- Hypoglycemia is the most common adverse reaction of insulin therapy. Monitor blood sugar frequently and observe for signs of hypoglycemia
- When used in an external subcutaneous insulin infusion pump, it should not be mixed with any other insulin or diluent
- Dosage increase may be required during infection, illness, stress, trauma, and pregnancy
- Insulin, particularly when given intravenously or in cases of poor glycemic control, can cause hypokalemia
- Severe, life-threatening allergic reactions, including anaphylaxis, may occur with insulin products
- Concomitant use of thiazolidinediones can cause dose related fluid retention, which may lead to or exacerbate heart failure, therefore monitor for signs and symptoms of heart failure and treat accordingly or consider discontinuation or dose reduction
Cautions: Use cautiously in
- Renal impairment
- Hepatic impairment
- Changes in dose of other hypoglycemic medications
- Infection
- Stress
- Illness
- Hypokalemia
- Change in diet or activity
Supplemental Patient Information
- Instruct patients on diet, exercise, blood or urine testing, proper administration of insulin, change in species of origin, type or purity of insulin, and management of hypoglycemia
- Advise patient to rotate subcutaneous injection sites and keep a record of sites used, to help prevent fatty tissue breakdown
Pregnancy Category:B
Breastfeeding: It is not known whether insulin aspart is excreted in breast milk; however no adverse reactions have been reported due to insulin in breastmilk. This information is based upon lactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 18 January 2011).
Pricing data from www.DrugStore.com in U.S.A.
- NovoLOG 100 UNIT/ML SOLN [Vial] (NOVO NORDISK)
10 ml = $142.99
30 ml = $399.98 - NovoLOG PenFill 100 UNIT/ML SOLN [Cartridge] (NOVO NORDISK)
15 ml = $264.59
45 ml = $755.97 - NovoLOG FlexPen 100 UNIT/ML SOLN [Box] (NOVO NORDISK)
15 ml = $268.99
45 ml = $759.99
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.